Reducing Urban Cervical Cancer Disparities

NCT06416150 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 546

Last updated 2024-10-26

No results posted yet for this study

Summary

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Conditions

Interventions

BEHAVIORAL

Stage 1 SOC

Participants will receive high Standard Care, consisting of a telephone call approximately one month before the appointment to confirm the appointment date for the baseline colposcopy appointment, followed by a notification letter including scheduled appointment date and clinic contact information should the clinic be unable to reach the patient by telephone.

BEHAVIORAL

Stage 1 HERS

Participants will receive text message appointment reminders and barriers messages. Text messages will be sent on a prescheduled basis over the course of 2 weeks preceding the scheduled target appointment.

BEHAVIORAL

Stage 2 HERS

Participants will receive another barriers assessment and another round of text message appointment reminders and barriers messages.

BEHAVIORAL

Stage 2 HERS+HC

Participants will receive another barriers assessment and another round of text message barriers counseling as well as health coaching (HC) after their missed appointment. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.

BEHAVIORAL

Stage 3 SOC

Participants will receive a telephone call before their 12-month follow-up appointments to remind participants about their upcoming appointment and schedule/reschedule if needed.

BEHAVIORAL

Stage 3 HERS

Participants will receive text message appointment reminders and barriers messages. Text messages will be sent on a prescheduled basis over the course of 2 weeks preceding the scheduled target appointment.

BEHAVIORAL

Stage 3 HERS+HC

Participants will receive text message barriers counseling as well as HC after their missed appointment. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.

BEHAVIORAL

Stage 4 HERS

Participants will receive another barriers assessment and another round of text message appointment reminders and barriers messages.

BEHAVIORAL

Stage 4 HERS+HC

Participants will receive another barriers assessment and another round of text message barriers counseling as well as HC. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • Temple University

    collaborator OTHER
  • University of South Carolina

    collaborator OTHER
  • Fox Chase Cancer Center

    lead OTHER

Principal Investigators

  • Suzanne M Miller, PhD · Fox Chase Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-28
Primary Completion
2027-04-30
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06416150 on ClinicalTrials.gov